T Hasegawa (4958) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
26 Oct, 2026Executive summary
9M FY2025 net sales rose 3.5% YoY to ¥54,548 million; operating profit, ordinary profit and net income fell 3.3%, 2.8% and 4.3%, respectively.
Sales growth was led by the Flavor Division and overseas markets, while higher personnel costs and goodwill amortization weighed on operating profit.
Financial highlights
Gross profit increased to ¥23,073 million from ¥22,073 million, while SG&A rose to ¥15,825 million from ¥14,579 million.
Operating profit was ¥7,247 million, ordinary profit ¥7,779 million and profit attributable to owners of parent ¥5,378 million for 9M FY2025.
Comprehensive income fell 50.5% YoY to ¥4,880 million, including a ¥779 million loss in available-for-sale securities valuation versus a ¥4,119 million gain a year earlier.
Net sales rose ¥1,842 million YoY; net income was reduced by lower ordinary profit and a ¥100 million loss on valuation of investment securities.
Outlook and guidance
FY2025 guidance remains unchanged: net sales ¥74,300 million (+3.7%), operating profit ¥9,970 million (+6.4%), ordinary profit ¥10,450 million (+7.5%), net income ¥7,580 million (+5.2%) and EPS ¥185.27.
FY2025 annual dividend forecast is ¥74 per share, up from ¥70 for FY2024; no revision to the dividend forecast.
Latest events from T Hasegawa
- Sales and profits advanced as overseas growth and the Vietnam acquisition supported results.4958
Q4 2026 - Sales and operating profit rose; full-year guidance was unchanged.4958
Q1 2024 - H1 sales and operating profit grew, led by flavors and stronger Asia and USA results.4958
Q2 2024 - Record FY2024 sales and profit growth underpin further expansion and FY2025 growth.4958
Q4 2024 - Nine-month sales and operating profit rose; FY outlook and dividend were revised.4958
Q3 2024 - Sales and profit grew, led by Asia and FX gains, while the USA segment weakened.4958
Q1 2025 - Asia-led growth lifted H1 sales and profit, while the USA segment swung to a loss.4958
Q2 2025 - FY2025 sales grew as profits fell; FY2026 guidance targets recovery and a ¥100 dividend.4958
Q4 2025 - H1 sales rose 4.9%, operating profit edged up 0.2%, and FY2026 guidance was unchanged.4958
Q2 2026